Randomized clinical trial comparing treatment outcomes including adverse events of preoperative drainage for acute cholecystitis with endoscopic ultrasound and percutaneous transhepatic approach

Randomized clinical trial comparing treatment outcomes including adverse events of preoperative drainage for acute cholecystitis with endoscopic ultrasound and percutaneous transhepatic approach - RCT comparing the outcomes of endoscopic ultrasound versus percutaneous transhepatic drainage as a preoperative drainage method for acute cholecystitis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047820

Enrollment

Registered

2022-05-23

Start date

2022-05-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute cholecystitis

Interventions

EUS-GBD PTGBD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute cholecystitis who are hospitalized at this hospital Age at the time of enrollment was between 20 and 90 years old Written consent for participation in the study has been obtained from the patients. Patients scheduled to undergo LC within 2 months after drainage. ECOG (Eastern Cooperative Oncology Group) performance status 0-3

Exclusion criteria

Exclusion criteria: Cases of postoperative reconstructed intestinal tract Cases with ascites on the liver surface Cases with difficulty to correct bleeding tendency or coagulation abnormality Poor gallbladder delineation and difficulty in securing the puncture route Cases with serious complications in other organs: ASA classification 3 or higher (excluding dialysis patients) ECOG performance status 4 (see Appendix #2) Cases with poor general condition and life expectancy judged to be less than 3 months Cases in which informed consent cannot be obtained

Design outcomes

Primary

Measure	Time frame
early adverse events	—

Secondary

Measure	Time frame
success rate of procedure,clinical efficacy improvement rate,procedure time, hospitalization duration,waiting time for surgery, surgical outcomes (blood loss, operative time, intraoperative adverse events,conversion rate to laparotomy),medical costs (from post-drainage to discharge date), patient QOL	—

Countries

Japan

Contacts

Public ContactAtsushi Okuda

Osaka Medical and Pharmaceutical University 2nd depaetment of internal medicine

ubuntu_koromo@yahoo.co.jp0726831221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026